Adaptimmune Ther ADR (ADAP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
Sales | 47,601 | 11,028 | 7,007 | 5,538 | 3,575 |
Gross Profit | 47,601 | 11,028 | 7,007 | 5,538 | 3,575 |
Operating Expenses | 45,945 | 38,270 | 49,997 | 49,290 | 53,556 |
Operating Income | 1,656 | -27,242 | -42,990 | -43,752 | -49,981 |
Other Income | 5 | -1,014 | 1,968 | -298 | 350 |
Pre-tax Income | 1,661 | -28,256 | -41,022 | -44,050 | -49,631 |
Income Tax | 625 | 994 | 399 | 470 | 634 |
Net Income Continuous | 1,036 | -29,250 | -41,421 | -44,520 | -50,265 |
Net Income | $1,036 | $-29,250 | $-41,421 | $-44,520 | $-50,265 |
EPS Basic Total Ops | 0.00 | -0.17 | -0.25 | -0.28 | -0.32 |
EPS Basic Continuous Ops | 0.01 | -0.17 | -0.25 | -0.28 | -0.32 |
EPS Diluted Total Ops | 0.00 | -0.17 | -0.25 | -0.28 | -0.32 |
EPS Diluted Continuous Ops | 0.01 | -0.17 | -0.25 | -0.28 | -0.32 |
EPS Diluted Before Non-Recurring Items | 0.01 | -0.18 | -0.24 | N/A | N/A |
EBITDA(a) | $3,501 | $-25,805 | $-41,499 | $-42,200 | $-48,386 |